Mutational Signatures in Esophageal Squamous Cell Carcinoma from Eight Countries with Varying Incidence

Esophageal squamous cell carcinoma (ESCC) shows remarkable variation in incidence that is not fully explained by known lifestyle and environmental risk factors. It has been speculated that an unknown exogenous exposure(s) could be responsible. Here we combine the fields of mutational signature analysis with cancer epidemiology to study 552 ESCC genomes from eight countries with varying incidence rates. Mutational profiles were similar across all countries studied. Associations between specific mutational signatures and ESCC risk factors were identified for tobacco, alcohol, opium and germline variants, with modest impacts on mutation burden. We find no evidence of a mutational signature indicative of an exogenous exposure capable of explaining differences in ESCC incidence. Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like (APOBEC)-associated mutational signatures single-base substitution (SBS)2 and SBS13 were present in 88% and 91% of cases, respectively, and accounted for 25% of the mutation burden on average, indicating that APOBEC activation is a crucial step in ESCC tumor development.

Citing Articles

Recurrent alterations are associated with esophageal adenocarcinoma brain metastases.

Lawson N, Ye L, Cho C, Zhao B, Mitchell T, Martin-Barrio I medRxiv. 2025; .

PMID: 40061311 PMC: 11888521. DOI: 10.1101/2025.02.19.25322558.

Geographic and age-related variations in mutational processes in colorectal cancer.

Diaz-Gay M, Dos Santos W, Moody S, Kazachkova M, Abbasi A, Steele C medRxiv. 2025; .

PMID: 40034755 PMC: 11875255. DOI: 10.1101/2025.02.13.25322219.

Comparison of actionable alterations in cancers with kinase fusion, mutation, and copy number alteration.

Suzuki S, Akahane T, Tanimoto A, Higashi M, Kitazono I, Kirishima M PLoS One. 2025; 20(1):e0305025.

PMID: 39847581 PMC: 11756797. DOI: 10.1371/journal.pone.0305025.

Impact of APOBEC3s on the occurrence, development and prognosis of esophageal squamous cell carcinoma.

Yang F, Xiao H, Dai X, Xu M, Li M, Bai J Future Oncol. 2025; 21(1):117-125.

PMID: 39840662 PMC: 11852747. DOI: 10.1080/14796694.2024.2442300.

Investigating the origins of the mutational signatures in cancer.

Boysen G, Alexandrov L, Rahbari R, Nookaew I, Ussery D, Chao M Nucleic Acids Res. 2025; 53(1).

PMID: 39778866 PMC: 11707540. DOI: 10.1093/nar/gkae1303.

References

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

Arnold M, Soerjomataram I, Ferlay J, Forman D . Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2014; 64(3):381-7. DOI: 10.1136/gutjnl-2014-308124. View

Abnet C, Arnold M, Wei W . Epidemiology of Esophageal Squamous Cell Carcinoma. Gastroenterology. 2017; 154(2):360-373. PMC: 5836473. DOI: 10.1053/j.gastro.2017.08.023. View

Murphy G, McCormack V, Abedi-Ardekani B, Arnold M, Camargo M, Dar N . International cancer seminars: a focus on esophageal squamous cell carcinoma. Ann Oncol. 2017; 28(9):2086-2093. PMC: 5834011. DOI: 10.1093/annonc/mdx279. View

Sheikh M, Poustchi H, Pourshams A, Etemadi A, Islami F, Khoshnia M . Individual and Combined Effects of Environmental Risk Factors for Esophageal Cancer Based on Results From the Golestan Cohort Study. Gastroenterology. 2019; 156(5):1416-1427. PMC: 7507680. DOI: 10.1053/j.gastro.2018.12.024. View

McCormack V, Menya D, Munishi M, Dzamalala C, Gasmelseed N, Leon Roux M . Informing etiologic research priorities for squamous cell esophageal cancer in Africa: A review of setting-specific exposures to known and putative risk factors. Int J Cancer. 2016; 140(2):259-271. PMC: 5763498. DOI: 10.1002/ijc.30292. View

Mello F, Melo G, Pasetto J, Silva C, Warnakulasuriya S, Rivero E . The synergistic effect of tobacco and alcohol consumption on oral squamous cell carcinoma: a systematic review and meta-analysis. Clin Oral Investig. 2019; 23(7):2849-2859. DOI: 10.1007/s00784-019-02958-1. View

Alexandrov L, Kim J, Haradhvala N, Huang M, Ng A, Wu Y . The repertoire of mutational signatures in human cancer. Nature. 2020; 578(7793):94-101. PMC: 7054213. DOI: 10.1038/s41586-020-1943-3. View

Alexandrov L, Jones P, Wedge D, Sale J, Campbell P, Nik-Zainal S . Clock-like mutational processes in human somatic cells. Nat Genet. 2015; 47(12):1402-7. PMC: 4783858. DOI: 10.1038/ng.3441. View

10.

Alexandrov L, Ju Y, Haase K, Van Loo P, Martincorena I, Nik-Zainal S . Mutational signatures associated with tobacco smoking in human cancer. Science. 2016; 354(6312):618-622. PMC: 6141049. DOI: 10.1126/science.aag0299. View

11.

Riva L, Pandiri A, Li Y, Droop A, Hewinson J, Quail M . The mutational signature profile of known and suspected human carcinogens in mice. Nat Genet. 2020; 52(11):1189-1197. PMC: 7610456. DOI: 10.1038/s41588-020-0692-4. View

12.

Scelo G, Riazalhosseini Y, Greger L, Letourneau L, Gonzalez-Porta M, Wozniak M . Variation in genomic landscape of clear cell renal cell carcinoma across Europe. Nat Commun. 2014; 5:5135. DOI: 10.1038/ncomms6135. View

13.

Gao Y, Chen Z, Li J, Hu X, Shi X, Sun Z . Genetic landscape of esophageal squamous cell carcinoma. Nat Genet. 2014; 46(10):1097-102. DOI: 10.1038/ng.3076. View

14.

Zhang L, Zhou Y, Cheng C, Cui H, Cheng L, Kong P . Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet. 2015; 96(4):597-611. PMC: 4385186. DOI: 10.1016/j.ajhg.2015.02.017. View

15.

Sawada G, Niida A, Uchi R, Hirata H, Shimamura T, Suzuki Y . Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population. Gastroenterology. 2016; 150(5):1171-1182. DOI: 10.1053/j.gastro.2016.01.035. View

16.

Li X, Wang M, Yang M, Dai H, Zhang B, Wang W . A mutational signature associated with alcohol consumption and prognostically significantly mutated driver genes in esophageal squamous cell carcinoma. Ann Oncol. 2018; 29(4):938-944. PMC: 5913594. DOI: 10.1093/annonc/mdy011. View

17.

Mangalaparthi K, Patel K, Khan A, Manoharan M, Karunakaran C, Murugan S . Mutational Landscape of Esophageal Squamous Cell Carcinoma in an Indian Cohort. Front Oncol. 2020; 10:1457. PMC: 7469928. DOI: 10.3389/fonc.2020.01457. View

18.

Martincorena I, Raine K, Gerstung M, Dawson K, Haase K, Van Loo P . Universal Patterns of Selection in Cancer and Somatic Tissues. Cell. 2017; 171(5):1029-1041.e21. PMC: 5720395. DOI: 10.1016/j.cell.2017.09.042. View

19.

Middlebrooks C, Rouf Banday A, Matsuda K, Udquim K, Onabajo O, Paquin A . Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors. Nat Genet. 2016; 48(11):1330-1338. PMC: 6583788. DOI: 10.1038/ng.3670. View

20.

Nik-Zainal S, Wedge D, Alexandrov L, Petljak M, Butler A, Bolli N . Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer. Nat Genet. 2014; 46(5):487-91. PMC: 4137149. DOI: 10.1038/ng.2955. View